Alembic Pharmaceuticals receives USFDA approval for Fingolimod Capsules ANDA EP News Bureau Apr 27, 2026 Approval for 0.5 mg capsules therapeutically equivalent to Novartis’ Gilenya; market size at US$ 145 million
